MX2023000283A - Terapia de nausea y vomito post-operatorio. - Google Patents
Terapia de nausea y vomito post-operatorio.Info
- Publication number
- MX2023000283A MX2023000283A MX2023000283A MX2023000283A MX2023000283A MX 2023000283 A MX2023000283 A MX 2023000283A MX 2023000283 A MX2023000283 A MX 2023000283A MX 2023000283 A MX2023000283 A MX 2023000283A MX 2023000283 A MX2023000283 A MX 2023000283A
- Authority
- MX
- Mexico
- Prior art keywords
- vomiting
- therapy
- post
- operative nausea
- patient
- Prior art date
Links
- 208000031649 Postoperative Nausea and Vomiting Diseases 0.000 title abstract 4
- 238000002560 therapeutic procedure Methods 0.000 title abstract 2
- 206010066962 Procedural nausea Diseases 0.000 abstract 1
- 206010066963 Procedural vomiting Diseases 0.000 abstract 1
- NTJOBXMMWNYJFB-UHFFFAOYSA-N amisulpride Chemical compound CCN1CCCC1CNC(=O)C1=CC(S(=O)(=O)CC)=C(N)C=C1OC NTJOBXMMWNYJFB-UHFFFAOYSA-N 0.000 abstract 1
- 229960003036 amisulpride Drugs 0.000 abstract 1
- 238000007681 bariatric surgery Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000008673 vomiting Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2010361.0A GB202010361D0 (en) | 2020-07-06 | 2020-07-06 | Therapy of post-operative nausea and vomiting |
| GBGB2108238.3A GB202108238D0 (en) | 2021-06-09 | 2021-06-09 | Thearpy of post-operative nausea and vomiting |
| PCT/GB2021/051720 WO2022008901A1 (en) | 2020-07-06 | 2021-07-06 | Therapy of post-operative nausea and vomiting |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023000283A true MX2023000283A (es) | 2023-02-09 |
Family
ID=77021661
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023000283A MX2023000283A (es) | 2020-07-06 | 2021-07-06 | Terapia de nausea y vomito post-operatorio. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230263770A1 (enExample) |
| EP (1) | EP4175631A1 (enExample) |
| JP (1) | JP2023538216A (enExample) |
| KR (1) | KR20230035095A (enExample) |
| CN (1) | CN115867271A (enExample) |
| AU (1) | AU2021305446A1 (enExample) |
| BR (1) | BR112023000167A2 (enExample) |
| CA (1) | CA3187665A1 (enExample) |
| IL (1) | IL299649A (enExample) |
| MX (1) | MX2023000283A (enExample) |
| WO (1) | WO2022008901A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250152595A1 (en) * | 2023-11-09 | 2025-05-15 | Lisa Myslinski | Medication to alleviate nausea with or without vomiting, vertigo, and pain |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201004020D0 (en) | 2010-03-11 | 2010-04-21 | Acacia Pharma Ltd | New therapeutic use |
| GB201618425D0 (en) * | 2016-11-01 | 2016-12-14 | Acacia Pharma Ltd | method |
| GB201702250D0 (en) * | 2017-02-10 | 2017-03-29 | Acacia Pharma Ltd | Method |
-
2021
- 2021-07-06 CN CN202180047918.XA patent/CN115867271A/zh active Pending
- 2021-07-06 US US18/014,545 patent/US20230263770A1/en active Pending
- 2021-07-06 JP JP2023500302A patent/JP2023538216A/ja active Pending
- 2021-07-06 BR BR112023000167A patent/BR112023000167A2/pt unknown
- 2021-07-06 CA CA3187665A patent/CA3187665A1/en active Pending
- 2021-07-06 EP EP21745393.5A patent/EP4175631A1/en active Pending
- 2021-07-06 AU AU2021305446A patent/AU2021305446A1/en active Pending
- 2021-07-06 WO PCT/GB2021/051720 patent/WO2022008901A1/en not_active Ceased
- 2021-07-06 KR KR1020237004132A patent/KR20230035095A/ko active Pending
- 2021-07-06 IL IL299649A patent/IL299649A/en unknown
- 2021-07-06 MX MX2023000283A patent/MX2023000283A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20230035095A (ko) | 2023-03-10 |
| WO2022008901A1 (en) | 2022-01-13 |
| CA3187665A1 (en) | 2022-01-13 |
| JP2023538216A (ja) | 2023-09-07 |
| AU2021305446A1 (en) | 2023-02-02 |
| IL299649A (en) | 2023-03-01 |
| CN115867271A (zh) | 2023-03-28 |
| US20230263770A1 (en) | 2023-08-24 |
| EP4175631A1 (en) | 2023-05-10 |
| BR112023000167A2 (pt) | 2023-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1762271A3 (en) | Rehydration composition | |
| MY145590A (en) | Phenylacetamides and their use as glucokinase modulators | |
| AU2002236795A1 (en) | Compositions and method of tissue superoxygenation | |
| AU2003229309A1 (en) | Acoustic contractility indicator | |
| SG136804A1 (en) | Treatment of b cell malignancies using combination of b cell depleting antibody and immune modulating antibody related applications | |
| BRPI0112044B8 (pt) | embalagem de produto medicinal para melhorar a obediência na terapia de erradicação de micróbios | |
| WO2005027993A3 (en) | Vascular access preservation in hemodialysis patients | |
| NO20062398L (no) | Daglig, oral, kontrollert frigivnings oksycodon-doserings form | |
| NO20032027L (no) | Effektive antitumorbehandlinger | |
| MX2023000283A (es) | Terapia de nausea y vomito post-operatorio. | |
| TWD227106S (zh) | 流體交換裝置 | |
| DE60322586D1 (en) | Post-operative weste | |
| MXPA05001885A (es) | El uso de una combinacion de ciclesonida y antihistaminas para el tratamiento de la rinitis alergica. | |
| DE60216901D1 (de) | Beschichtetes biomedizinisches produkt | |
| TWD220257S (zh) | 醫療用流體輸送裝置 | |
| WO2023240199A3 (en) | Fitusiran for the treatment of hemophilia a and b | |
| BR112022025911A2 (pt) | Combinação de um inibidor de bromodomínio de cbp/p300 e um inibidor de egfr para uso no tratamento de um cpcnp com egfr mutante | |
| DE60222383D1 (de) | Medikament zur verabreichung von amifostin und verwandten wirkstoffen | |
| EA201991667A1 (ru) | Экстренное лечение постоперационной тошноты и рвоты | |
| AU2003270470A1 (en) | Vitreoretinal tamponades based on fluorosilicone fluids | |
| NO20003510L (no) | Fett-bindende polymerer | |
| GEP20063758B (en) | Benzothia(Dia)Zine Derivatives and Method for Their Use as AMPA Modulators | |
| WO2006124573A3 (en) | Treatment of cancer with 2-deoxyglucose | |
| Youel et al. | Skeletal suspension in the management of severe burns in children. A sixteen-year experience. | |
| WO2022235791A3 (en) | Combination therapies for the treatment of cancer |